Lasso Peptide Surgery

Reflecting work in the Chu Lab

Published here October 28, 2026

Chemoenzymatic Modification of Microcin J25 with Single-Residue Precision Provides New-to-Nature Lasso Peptides

Chia-Yu Tsai, Hsueh-Wei Chung, Yi-Ping Huang, Chi-Fon Chang, Kwun-Yung Cheung, Hui-Ni Tan, Hsiao-Yun Huang, Li-Kang Sung, Julian D. Hegemann, Yi-Tsu Chan, and John Chu

JACS Au 2026, 6, 4618–4625. https://doi.org/10.1021/jacsau.6c00700

View Original Publication


Microcin J25, MccJ25, is a lasso peptide whose mechanical interlocking confers exceptional stability, but that same topology has made precise chemical editing at specific loop positions difficult. Earlier approaches to noncanonical amino acid incorporation relied on amber suppression or total chemical synthesis of the linear precursor followed by cyclization; any modification had to be tolerated by the biosynthetic enzymes McjB and McjC. A disulfide-based workaround produced mechanically interlocked molecules but introduced a bond unstable in the presence of reducing agents. Attempts to open the lasso loop cleanly with common proteases all failed: trypsin and V8 protease gave no cleavage, α-chymotrypsin achieved only approximately 40% single cleavage after 72 hours, and pancreatin and proteinase K each produced complex mixtures or non-specific cleavage, leaving no reliable entry point for site-selective chemical editing.

Researchers in the Chu Lab at National Taiwan University, published in JACS Au, identified thermolysin as the one protease that cleaves MccJ25 site-selectively at the Phe10–Val11 bond, yielding a single-cut [2]rotaxane; prolonged incubation releases the Val-Gly dipeptide to give a double-cut intermediate. Because MccJ25 lacks basic residues, the exposed N-terminus is the sole nucleophilic site, enabling regioselective installation of a preactivated building block, though a large excess of 120 equivalents was required, presumably because restoration of the lasso structure is energetically unfavorable due to its high strain, and multiple rounds of HPLC purification reduced the overall isolated yield to approximately 2.5%. Because the building-block step is purely chemical, it is compatible, in principle, with a nearly unlimited range of noncanonical entities, and the team used it to prepare nine new-to-nature lasso peptides bearing loop-size changes, D-form amino acids, N-methylated amino acids, and a naphthalene moiety.

The authors propose that this chemoenzymatic strategy will enable access to diverse mechanically interlocked molecules tailored for biomedical applications beyond antibacterial use, and note that the workflow is applicable in principle to other sites in MccJ25 and to other lasso peptides wherever a defined incision or excision can be generated, though this broader applicability was not demonstrated in the present work. Why some variants lost antibacterial activity whereas others retained it will require further investigation. Structural data, antibacterial profiling, and activity comparisons across variants are available in the original publication.


Author

Professor John Chu earned his BSc degree from National Taiwan University and his Ph.D. degree in Chemistry from Scripps Research under the supervision of M. Reza Ghadiri. He then underwent two postdoctoral trainings, working with Alanna Schepartz at Yale University and Sean Brady at Rockefeller University. In 2019, he returned to his alma mater to establish his independent research group. He focuses on microbial natural products and views them broadly as the chemical language that mediates microbial interactions with each other and the environment. By using a combination of bioinformatics, molecular biology, and synthetic methods, the Chu laboratory seeks to uncover new chemical and biological principles through the study of natural products.

Lasso Peptide Surgery

Author

Chia-Yu Tsai earned his BSc degree from National Tsing Hua University. He then obtained a MS degree from National Taiwan University, where he combined enzymatic and chemical approaches to manipulate the lasso peptide MccJ25. Chia-Yu is currently a Ph.D. student at the UF Scripps Institute.